Trademark Overview
On Friday, June 20, 2025, a trademark application was filed for METFORMINT with the United States Patent and Trademark Office. The USPTO has given the METFORMINT trademark a serial number of 99245377. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 20, 2025. This trademark is owned by Aspargo Laboratories, Inc.. The METFORMINT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of diabetes and pre-diabetes, and for managing blood sugar levels; Pharmaceutical preparations for the treatment of diabetes and pre-diabetes, and for managing blood sugar levels administered as an oral spray; Anti-diabetic pharmaceuticals